Renal cell carcinoma is the tenth most common malignancy in the USA, with upwards of 61,000 new cases and resulting in more than 14,000 deaths annually. Although partial nephrectomy remains the standard treatment, image-guided nephron-sparing ablative techniques including cryoablation, radiofrequency ablation, and microwave ablation have emerged as treatment options in certain patient populations.
Ablative therapies have high technical successes, low tumor recurrence rates, and preserve renal parenchymal volume. The purpose of this article is to provide an update on ablation therapies for small renal masses.
Current urology reports. 2016 Mar [Epub]
Benjamin J Shin, Jeffrey Forris Beecham Chick, S William Stavropoulos
Department of Radiology, Division of Interventional Radiology, University of Pennsylvania Health System 1 Silverstein, 3400 Spruce Street, Philadelphia, PA, 19104, USA. , Department of Radiology, Division of Interventional Radiology, University of Pennsylvania Health System 1 Silverstein, 3400 Spruce Street, Philadelphia, PA, 19104, USA. , Department of Radiology, Division of Interventional Radiology, Perelman School of Medicine at the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA, 19104, USA.